An interventional study of Financial psycho-oncology intervention in Cancer, Financial Hardship and Psychological Distress, sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this pilot, feasibility study is to evaluate the feasibility and preliminary impact of a finance-specific psycho-oncology intervention, as well as to explore perceptions of and experiences with this financial psycho-oncology intervention for patients with cancer experiencing financial hardship. The main questions it aims to answer are:
Patients enrolled in the intervention will receive 2, 60-minute long, finance-specific psycho-oncology sessions per month over the course of 3 months, for a total of 6 sessions over the course of the intervention. Patients will complete surveys during intervention enrollment and after intervention completion to assess secondary outcomes of financial hardship, psychological distress, stress, and anxiety. Individuals who consent to the financial psycho-oncology intervention will also be invited to participate in a 30-minute semi-structured interview to explore their perceptions of and experiences with the financial psycho-oncology intervention, including concepts of participation and engagement, relevance and acceptability, content and understanding, logistics and practicality, and potential impact.
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's planned enrollment of 20 is below the median of 60 across 7,716 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →University of Alabama at Birmingham is the lead sponsor of 1,422 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Financial psycho-oncology intervention
Program which integrates emotional support, coping strategies, and financial psychoeducation to enhance patients' capacity to cope with both their emotional and financial burdens due to cancer.
Recruitment as a measure of feasibility
50% of contacted patients consenting to participate
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Retention as a measure of feasibility
70% of consenting patients completing the program per protocol
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Completion as a measure of feasibility
\<15% missing survey data
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Financial hardship
as measured by COmprehensive Score for financial Toxicity (COST)
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Psychological distress
as measured by National Comprehensive Cancer Network Distress Thermometer and Problem List
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Perceived stress
as measured by Perceived Stress Scale (PSS-10)
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Anxiety
as measured by PROMIS Emotional Distress - Anxiety - Short Form 4
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Change in Depression
as measured by PROMIS Emotional Distress - Depression - Short Form 4
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 8 months is below that.
Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham →